VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
1.490
-0.010 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
1.470
-0.020 (-1.34%)
After-hours: Apr 28, 2026, 7:52 PM EDT
VivoSim Labs Employees
VivoSim Labs had 13 employees as of March 31, 2025. The number of employees decreased by 7 or -35.00% compared to the previous year.
Employees
13
Change (1Y)
-7
Growth (1Y)
-35.00%
Revenue / Employee
$10,143
Profits / Employee
-$87,643
Market Cap
4.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| AIM ImmunoTech | 21 |
| Soligenix | 14 |
| Revelation Biosciences | 9 |
| Dermata Therapeutics | 9 |
| Alzamend Neuro | 6 |
| Galmed Pharmaceuticals | 6 |
| 60 Degrees Pharmaceuticals | 3 |
VIVS News
- 18 hours ago - VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing - GlobeNewsWire
- 27 days ago - VivoSim Announces Pricing of up to a $4 Million Public Offering - GlobeNewsWire
- 5 weeks ago - VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs - GlobeNewsWire
- 2 months ago - VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales - GlobeNewsWire
- 2 months ago - VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego - GlobeNewsWire
- 3 months ago - VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China - GlobeNewsWire
- 4 months ago - VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - GlobeNewsWire
- 9 months ago - VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer - GlobeNewsWire